FDA Approved: DULOXETINE — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals' supplemental ANDA for a generic duloxetine product (ANDA204343). Duloxetine is indicated for major depressive disorder, gen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathic Pain
• Fibromyalgia
• Generalized Anxiety Disorder
• Low Back Pain
• Major Depressive Disorder
• Musculoskeletal Pain
• Osteoarthritis Pain

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

SUPPL AP for DULOXETINE (DULOXETINE)